Skip to content

Clinical trials

Phase 2 trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Country / region: Saudi Arabia Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20062
20072
20084
20092
20103
20113
20121
20131
201411
20155
20165
20175
20189
20195
20209
20214
20226
20232
20244
20258
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Unknown status16
Active, not recruiting9
Terminated8
Recruiting8
Withdrawn3
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
Imam Abdulrahman Bin Faisal University6
King Faisal Specialist Hospital & Research Center6
National Guard Health Affairs5
Riyadh Colleges of Dentistry and Pharmacy5
Janssen Research & Development, LLC3
King Faisal University3
Ministry of Health, Saudi Arabia3
Children's Oncology Group2
Eli Lilly and Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung4
Lung Neoplasms3
Anemia, Sickle Cell2
Biliary Tract Neoplasms2
Breast Neoplasms2
COVID-192
Colorectal Neoplasms2
Diabetes Mellitus, Type 12
Dry Socket2
Glioblastoma2

Trials

Showing 26 to 50 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.